Matches in SemOpenAlex for { <https://semopenalex.org/work/W4293113303> ?p ?o ?g. }
- W4293113303 endingPage "2189" @default.
- W4293113303 startingPage "2177" @default.
- W4293113303 abstract "As patents for multiple sclerosis (MS) therapies expire, follow-on disease-modifying treatments (FO-DMTs) become available at reduced cost. Concerns exist that cheaper FO-DMTs are used simply to reduce healthcare costs. However, the well-being of people with MS should take priority.To identify best practices for FO-DMT development and use by agreeing on principles and consensus statements through appraisal of published evidence.Following a systematic review, we formulated five overarching principles and 13 consensus statements. Principles and statements were voted on by a multidisciplinary panel from 17 European countries, Argentina, Canada and the United States.All principles and statements were endorsed by >80% of panellists. In brief, FO-DMTs approved within highly regulated areas can be considered effective and safe as their reference products; FO-DMTs can be evaluated case by case and do not always require Phase III trials; long-term pharmacovigilance and transparency are needed; there is lack of evidence for multiple- and cross-switching among FO-DMTs; and education is needed to address remaining concerns.Published data support the use of FO-DMTs in MS. The consensus may aid shared decision-making. While our consensus focused on Europe, the results may contribute to enhanced quality standards for FO-DMTs use elsewhere." @default.
- W4293113303 created "2022-08-26" @default.
- W4293113303 creator A5005633880 @default.
- W4293113303 creator A5008086092 @default.
- W4293113303 creator A5008338463 @default.
- W4293113303 creator A5018395899 @default.
- W4293113303 creator A5023725739 @default.
- W4293113303 creator A5025079255 @default.
- W4293113303 creator A5034338375 @default.
- W4293113303 creator A5034380106 @default.
- W4293113303 creator A5038680506 @default.
- W4293113303 creator A5053403281 @default.
- W4293113303 creator A5058528168 @default.
- W4293113303 creator A5063615479 @default.
- W4293113303 creator A5069134946 @default.
- W4293113303 creator A5070347244 @default.
- W4293113303 creator A5084430523 @default.
- W4293113303 creator A5088591482 @default.
- W4293113303 date "2022-08-24" @default.
- W4293113303 modified "2023-09-27" @default.
- W4293113303 title "Use of follow-on disease-modifying treatments for multiple sclerosis: Consensus recommendations" @default.
- W4293113303 cites W1908392151 @default.
- W4293113303 cites W2007367842 @default.
- W4293113303 cites W2115586444 @default.
- W4293113303 cites W2141163213 @default.
- W4293113303 cites W2262703742 @default.
- W4293113303 cites W2403703304 @default.
- W4293113303 cites W2480666060 @default.
- W4293113303 cites W2550055621 @default.
- W4293113303 cites W2560455300 @default.
- W4293113303 cites W2572141928 @default.
- W4293113303 cites W2591088516 @default.
- W4293113303 cites W2748489847 @default.
- W4293113303 cites W2750911325 @default.
- W4293113303 cites W2766388803 @default.
- W4293113303 cites W2767123116 @default.
- W4293113303 cites W2787204655 @default.
- W4293113303 cites W2890553021 @default.
- W4293113303 cites W2900551092 @default.
- W4293113303 cites W2901678108 @default.
- W4293113303 cites W2902059538 @default.
- W4293113303 cites W2913222468 @default.
- W4293113303 cites W2925207909 @default.
- W4293113303 cites W2944807577 @default.
- W4293113303 cites W2945752394 @default.
- W4293113303 cites W2960106648 @default.
- W4293113303 cites W2973908960 @default.
- W4293113303 cites W2991623378 @default.
- W4293113303 cites W3012498725 @default.
- W4293113303 cites W3013519416 @default.
- W4293113303 cites W3015094841 @default.
- W4293113303 cites W3042308502 @default.
- W4293113303 cites W3044372145 @default.
- W4293113303 cites W3083922376 @default.
- W4293113303 cites W3085906625 @default.
- W4293113303 cites W3132700063 @default.
- W4293113303 cites W3211677769 @default.
- W4293113303 cites W3214657680 @default.
- W4293113303 cites W4200361830 @default.
- W4293113303 doi "https://doi.org/10.1177/13524585221116269" @default.
- W4293113303 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36000489" @default.
- W4293113303 hasPublicationYear "2022" @default.
- W4293113303 type Work @default.
- W4293113303 citedByCount "2" @default.
- W4293113303 countsByYear W42931133032023 @default.
- W4293113303 crossrefType "journal-article" @default.
- W4293113303 hasAuthorship W4293113303A5005633880 @default.
- W4293113303 hasAuthorship W4293113303A5008086092 @default.
- W4293113303 hasAuthorship W4293113303A5008338463 @default.
- W4293113303 hasAuthorship W4293113303A5018395899 @default.
- W4293113303 hasAuthorship W4293113303A5023725739 @default.
- W4293113303 hasAuthorship W4293113303A5025079255 @default.
- W4293113303 hasAuthorship W4293113303A5034338375 @default.
- W4293113303 hasAuthorship W4293113303A5034380106 @default.
- W4293113303 hasAuthorship W4293113303A5038680506 @default.
- W4293113303 hasAuthorship W4293113303A5053403281 @default.
- W4293113303 hasAuthorship W4293113303A5058528168 @default.
- W4293113303 hasAuthorship W4293113303A5063615479 @default.
- W4293113303 hasAuthorship W4293113303A5069134946 @default.
- W4293113303 hasAuthorship W4293113303A5070347244 @default.
- W4293113303 hasAuthorship W4293113303A5084430523 @default.
- W4293113303 hasAuthorship W4293113303A5088591482 @default.
- W4293113303 hasConcept C118552586 @default.
- W4293113303 hasConcept C17744445 @default.
- W4293113303 hasConcept C177713679 @default.
- W4293113303 hasConcept C199539241 @default.
- W4293113303 hasConcept C2779473830 @default.
- W4293113303 hasConcept C2780035454 @default.
- W4293113303 hasConcept C2780233690 @default.
- W4293113303 hasConcept C57658597 @default.
- W4293113303 hasConcept C71924100 @default.
- W4293113303 hasConceptScore W4293113303C118552586 @default.
- W4293113303 hasConceptScore W4293113303C17744445 @default.
- W4293113303 hasConceptScore W4293113303C177713679 @default.
- W4293113303 hasConceptScore W4293113303C199539241 @default.
- W4293113303 hasConceptScore W4293113303C2779473830 @default.
- W4293113303 hasConceptScore W4293113303C2780035454 @default.
- W4293113303 hasConceptScore W4293113303C2780233690 @default.